IP Library Patent Application 17727502
Patent Application
App. No. 17/727,502

UNIQUE THERAPEUTIC DOSE FOR NMES SYSTEMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/727,502
Abstract

This disclosure describes various aspects of a unique therapeutic does for an NMES system. In some embodiments, the system includes one or more electrodes and one or more controls that execute a therapy session program. The therapy session program causes the controller to implement a pulse to the one or more electrodes that, when viewed on a graph of amplitude vs. time, create a “chair” shape with an exponentially decreasing amplitude. In some embodiments, the pulse is considerably longer (e.g., 5 ms) than those implemented in the past (e.g., 300 μs). In some embodiments, the pulse is held at a non-zero amplitude after an exponential decrease for a period of time before a non-electrical relaxation time period is implemented by the one or more controllers.

Claims (62)

1 . A system for providing a unique neuromuscular electrical stimulation (NMES) therapeutic dose comprising:

one or more electrodes, and

one or more controllers;

wherein the one or more controllers are configured to implement an electrical stimulation pulse is sufficient to cause muscle contraction when the one or more electrodes are placed on a user's skin;

wherein the one or more controllers are configured to execute a therapy session program;

wherein the therapy session program comprises a plurality of cycles;

wherein the plurality of cycles comprises one or more electrical stimulation time periods and one or more non-electrical relaxation time periods;

wherein the one or more electrical stimulation time periods are configured to cause the muscle contraction;

wherein the one or more non-electrical relaxation time periods are configured to not cause the muscle contraction;

wherein the one or more electrical stimulation time periods each comprise the electrical stimulation pulse which comprises a pulse profile; and

wherein the pulse profile is one or more of asymmetrical, monophasic, and complex.

2 . The system of claim 1 ,

wherein the pulse profile comprises an initial linear increasing portion; and

wherein the pulse profile comprising an exponentially decreasing portion following a peak of the initial linear increasing portion.

3 . The system of claim 2 ,

wherein the exponentially decreasing portion does not exponentially decrease to a substantially zero electrical power.

4 . The system of claim 2 ,

wherein the exponentially decreasing portion does not exponentially decrease into one of the one or more non-electrical relaxation time periods.

5 . The system of claim 2 ,

wherein when displayed on a graph, the exponentially decreasing portion comprises a substantially vertically decreasing section at a beginning;

wherein the substantially vertically decreasing section transitions to an exponentially decreasing section; and

wherein the exponentially decreasing section transitions to a substantially horizontal section at an end of the exponentially decreasing section.

6 . The system of claim 5 ,

wherein when the graph is a graph of intensity and/or amplitude vs time, and when the pulse profile between two non-electrical relaxation time periods is defined on the graph, a scale of the graph is such that a peak on an amplitude vertical axis of the pulse profile is at least twice a width of a pulse profile time along a time horizontal axis.

7 . The system of claim 5 ,

wherein the one or more controllers are configured to maintain a non-zero electrical intensity execution at the substantially horizontal section for a predetermined time before a zero electrical intensity execution is implemented.

8 . The system of claim 7 ,

a final decreasing portion following the exponentially decreasing section comprises the zero electrical intensity execution by the one or more controllers.

9 . The system of claim 8 ,

wherein the final decreasing portion comprises a substantially linear decreasing profile which joins to a non-electrical relaxation time period.

10 . A system for providing a unique neuromuscular electrical stimulation (NMES) therapeutic dose comprising:

one or more electrodes, and

one or more controllers;

wherein the one or more controllers are configured to implement an electrical stimulation pulse is sufficient to cause muscle contraction when the one or more electrodes are placed on a user's skin;

wherein the one or more controllers are configured to execute a therapy session program;

wherein the therapy session program comprises a plurality of cycles;

wherein the plurality of cycles comprises one or more electrical stimulation time periods and one or more non-electrical relaxation time periods;

wherein the one or more electrical stimulation time periods are configured to cause the muscle contraction;

wherein the one or more non-electrical relaxation time periods are configured to not cause the muscle contraction;

wherein the one or more electrical stimulation time periods each comprise the electrical stimulation pulse which comprises a pulse profile; and

wherein the pulse profile is executed for a time duration between 3 and 7 milliseconds (ms).

11 . The system of claim 10 ,

wherein a duration of the electrical stimulation pulse is between 4 and 6 ms.

12 . The system of claim 10 ,

wherein the electrical stimulation pulse is not a square wave.

13 . The system of claim 10 ,

wherein the electrical stimulation pulse is not sinusoidal.

14 . The system of claim 10 ,

wherein the therapy session program is configured to execute for 17 to 23 minutes.

wherein the therapy session program comprises between 8 and 15 minutes of muscle contraction time.

15 . The system of claim 11 ,

wherein the therapy session program is configured to execute for 19 to 21 minutes.

wherein the therapy session program comprises between 10 and 12 minutes of muscle contraction time.

16 . The system of claim 10 ,

wherein the pulse profile comprises an initial linear increasing portion; and

wherein the pulse profile comprising an exponentially decreasing portion following a peak of the initial linear increasing portion.

17 . The system of claim 16 ,

wherein when displayed on a graph, the exponentially decreasing portion comprises a substantially vertically decreasing section at a beginning;

wherein the substantially vertically decreasing section transitions to an exponentially decreasing section; and

wherein the exponentially decreasing section transitions to a substantially horizontal section.

18 . The system of claim 17 ,

wherein the one or more controllers are configured to maintain a non-zero electrical intensity execution at the substantially horizontal section for a predetermined time before a zero electrical intensity execution is implemented.

Assignments (2)
SECURITY INTEREST Recorded Nov 30, 2023
From: MOTIVE HEALTH, INC.
To: RESEARCH CORPORATION TECHNOLOGIES, INC.
Reel/Frame 065725/0760 →
CHANGE OF NAME Recorded Aug 3, 2023
From: CYMEDICA ORTHOPEDICS, INC.
To: MOTIVE HEALTH, INC.
Reel/Frame 064480/0643 →